Varsha Fresella

Varsha Fresella has a diverse work experience in the financial planning and analysis field. Varsha is currently serving as the Executive Director of Financial Planning and Analysis at Iveric Bio, An Astellas Company since January 2022. Prior to this, they worked at Roivant Sciences as a Financial Planning & Analysis professional from March 2019 to December 2021. Varsha has also held significant positions at The Medicines Company and Hoffmann-La Roche Inc, where they served as Vice President of Financial Planning and Analysis and Associate Director of Finance, respectively. Throughout their career, Varsha has demonstrated expertise in budgeting, planning, reporting, and operational improvement. Varsha has successfully coordinated activities globally and cross-functionally, providing impactful analysis and decision support to executives to enhance performance and value.

Varsha Fresella earned a Bachelor of Science degree in Accounting from Rutgers University. Varsha also obtained a certification as a Certified Public Accountant from the Board of Accountancy. No additional information is provided about the start and end years of their education or when they obtained their certification.